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Background: Psychotic disorders are characterized by large heterogeneity in clinical presentation, response to treatment and cognitive functioning. Indeed, there is evidence of the presence of cognitive subgroups of patients across affective and non-affective psychosis. However, very little is known about these subgroups in first episode psychosis (FEP) and whether they can be informative about course of illness, particularly response to treatment. The aim of this study is to investigate the number and the pattern of cognitive clusters in FEP, their external validity and association with treatment response at 12-week and 1-year follow up. Methods: The sample was composed by a total of 212 participants including 105 FEP patients from the South London and Maudsley Foundation Trust and 107 Healthy Controls (HC). All participants underwent a comprehensive clinical and neurocognitive battery. Z-score [mean=0, and standard deviation (SD)=1] were created for the whole sample based on the neurocognitive performance of the HCs. Treatment response at 12-week and 1-year follow-up was used to explore potential utility of subtypes in predicting response to treatment. Hierarchical cluster analysis was carried out to determine the number of cognitive clusters in FEP patients. A series of analyses of variance were carried out to determine if FEP clusters differed among each other in relation to demographic and clinical characteristics, level of functioning and from the HC sample in term of cognitive performance. Logistic regression was used to explore whether cognitive clustering was predictive of treatment response at 12-week and 1-year FU. Results: Four cognitive clusters emerged: one with near normal cognition (42.9% of the FEP patients) with a general cognitive score of z=-0.20, one with selected cognitive deficits (14.3%) in the domains of verbal memory, processing speed and executive functions (general cognitive score of z=-0.55); and two severe deficit clusters consisting in one cluster with severe deficits (33.3%; general score of z=-1.48) and the other with a deeply compromised cognitive ability (9.55%; general cognitive score of z=-2.34). There were no significant differences between clusters in terms of clinical features at baseline (including diagnosis, positive and negative symptoms, medication), apart from the level of functioning that was significantly lower in the severely compromised cluster compared to the near normal cognition cluster. It emerged that majority (about 68%) of the patients from the near normal cognition cluster were responsive to treatment, whilst the majority of the selective and severely impaired clusters did not respond to treatment at 12-week follow-up. There were no significant results with regard to treatment response at 1-year FU. Discussion: Distinct patterns of cognitive impairments exist within FEP that might be characterized by different response to treatment. Clinical presentation at the onset of the illness is not useful in predicting response to treatment later on in the course of the illness, while cognitive functioning might be a more valid indicator. Cognitive stratification could represent a promising way forward to elucidate pathophysiology of psychosis and to provide tailored interventions. 
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Background: Neurocognitive impairments are a core feature of psychosis and major depressive disorder (MDD) and are associated with poorer functioning outcomes in these illnesses. Individuals at ultra-high risk (UHR) for psychosis have been shown to experience mild but significant cognitive impairments relative to healthy controls. Evidence suggests neurocognitive deficits are useful predictors of transition to psychotic disorder, although there is inconsistency regarding the specific domains implicated. Furthermore, depression is common in the UHR population, but the relationship between neurocognitive impairment and depression in UHR has not been investigated. The aim of this study was to examine neurocognitive functioning in UHR participants at baseline and whether neurocognitive performance is associated with i) transition to psychosis; ii) depressive disorder; and iii) functioning at medium-term follow-up (median 24 months). Methods: Secondary analysis of data collected as part of a multi-centre RCT of omega-3 fatty acids and cognitive behavioural case management (NEURAPRO) for individuals at UHR for psychosis was conducted. Baseline, 6, 12 and 24-month (median) assessments relevant to the current study included the Comprehensive Assessment of the At-Risk Mental State (CAARMS), Structured Clinical Interview for DSM-IV (SCID), Brief Assessment of Cognition for Schizophrenia (BACS), MontgomeryÅsberg Depression Rating Scale (MADRS) and Social and Occupational Functioning Assessment Scale (SOFAS). The analysis was conducted on the 287 UHR participants (129 males, 158 females) who completed these measures. Hierarchical Cox proportional hazards regression was used to examine neurocognitive predictors of transition to psychosis, while hierarchical logistic and linear regressions were used to identify neurocognitive predictors of MDD and functioning, respectively. Results: Mean z-scores at baseline indicated that the UHR participants performed on average a quarter to half a standard deviation below healthy people in most domains (range mean z=-0.24 to -0.47), except for executive functioning (mean z=0.16, SD=1.21). One hundred and nineteen (41.5%) participants met criteria for MDD at baseline. Thirty-eight (13.2%) participants transitioned to psychosis over 24 months. Results showed that poorer Executive (p=.01) and Motor (p=.03) functions were predictive of transition to psychosis over 24 months, after controlling for other clinical and treatment variables. Forty-eight (16.7%) participants met criteria for MDD at 24 months. Faster Processing Speed significantly predicted MDD at 24 months (p=.01), but failed to retain significance after controlling for other factors, with baseline and past MDD history emerging as the strongest predictors of MDD at medium-term follow-up (both p<.001). After adjustment for IQ and baseline functioning, functional outcomes at 6, 12 and 24 months were predicted by baseline Processing Speed. Discussion: These findings suggest that neurocognitive abilities are important predictors of transition to psychosis and functional outcomes within the UHR population, but hold minimal value in predicting MDD after controlling for history of MDD. Further research is needed that examines trajectory of neurocognition over time in UHR and in relation to psychopathology and functioning outcomes.
